IMMURON
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 14 Mar 2024)
What this means for you
Registered since 14 Aug 2018. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 14 Aug 2028: the §8 & §9 renewal).
Record
- Serial number
- 87262018
- Registration number
- 5541767
- Mark type
- Word mark
- Filed
- 08 Dec 2016
- Published for opposition
- 28 Nov 2017
- Registered
- 14 Aug 2018
- Next maintenance filing
- §8 & §9 renewal, due by 14 Aug 2028 (grace period to 14 Feb 2029)
- Attorney of record
- Jeremy W. Miller
Goods and services
- Class 005 — Pharmaceuticals: Non-prescription pharmaceutical and biopharmaceutical preparations, namely, non-prescription medicaments, excluding anti-metabolic drugs, for treatment or prophylaxis of gastrointestinal disorders; and non-prescription medicaments, excluding anti-metabolic drugs, for treatment or phophylaxis of diarrhea
Owner
- IMMURON LIMITED, BLACKBURN NORTH, VIC, AU
- IMMURON LIMITED, BLACKBURN NORTH, VIC, AU
- IMMURON LIMITED, BLACKBURN NORTH, VIC, AU
Prosecution history
- 14 Mar 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 14 Mar 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 14 Mar 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 20 Sept 2023 — TEAS SECTION 8 & 15 RECEIVED
- 14 Aug 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 14 Aug 2018 — REGISTERED-PRINCIPAL REGISTER
- 11 Jul 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 Jul 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 09 Jul 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Jun 2018 — USE AMENDMENT FILED
- 09 Jul 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 14 Jun 2018 — TEAS STATEMENT OF USE RECEIVED
- 23 Jan 2018 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Nov 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Nov 2017 — PUBLISHED FOR OPPOSITION